Turning Probabilities Into Realities

  1. Multidistrict Litigation
  2.  → Zantac’s link to cancer

Zantac’s link to cancer

On Behalf of | Feb 17, 2021 | Multidistrict Litigation, product liability |

Many people in Texas have taken Zantac over the years. Introduced in 1983, this popular prescription has two functions as both an antacid and an antihistamine, commonly used to treat existing heartburn or to prevent it. Zantac is also often prescribed to people with GERD or stomach ulcers. However, Zantac has recently been linked to the development of some cancers. People who take or have taken this drug need to be informed of the risks it poses.

The role of NDMA

NDMA, or N-nitrosodimethylamine, is a substance found in Zantac that has also been linked to the development of cancer. NDMA isn’t a drug: It’s commonly found in foods like cured meats. It’s been normal for people to ingest this substance, but in recent years, there’s been a push to warn people about how dangerous it can be. Numerous cancers have been linked to NDMA. Esophageal, bladder, gastric, lung and liver cancer are among the risks for people who consume NDMA.

Government advisory

In 2019, the FDA discovered NDMA in Zantac and issued an alert to patients who take the drug. Since then, many class-action lawsuits have been started. One important fact is that the amount of NDMA in Zantac increases over time. Expiration dates are a big issue because of that. There’s also some evidence that the makers of Zantac and generic ranitidine covered up the presence of NDMA in their products.

If you or a loved one has been prescribed Zantac, it may be a good idea to contact a lawyer. Multidistrict litigation in the form of class-action suits can help people get the compensation they deserve for their pain and suffering related to Zantac use. An experienced attorney who understands personal injury may be able to help you get the damages you deserve.